Stem cell treatment for macular degeneration and Stargardt's

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

First Patients With Macular Degeneration and Stargardt’s Disease Receive Stem Cell Treatment

Posted By Irv Arons On July 21, 2011 @ 6:12 pm In Clinical Trials,Consultant Articles,Research,Retina,Stem Cell Therapies | Comments Disabled

Advanced Cell Technology announced the dosing of the first patients in each of its two Phase 1/2 clinical trials for Stargardt’s macular dystrophy and dry age-related macular degeneration (dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The patients were treated Tuesday (July 12) by Steven Schwartz, M.D., Ahmanson Professor of Ophthalmology at the David Geffen School of Medicine at UCLA and retina division chief at UCLA’s Jules Stein Eye Institute.

For the complete story please follow this link. ^[1]

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/005734-first-patients-with-macular-degeneration-and-stargardts-disease-receive-stem-cell-treatment/

URLs in this post:

[1] link.: http://tinyurl.com/ophthstemcells-update9

Click here to print.